Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VMP vs VTP Induction and VT vs VP Maintenance in Elderly Multiple Myeloma
NCT00443235Phase 3Completed
- Sponsor
- Fundación PETHEMA
- Start
- Mar 2005
- Primary completion
- Mar 2007
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of bortezomib in multiple myeloma (MM), sponsored by Fundación PETHEMA. Started Mar 2005; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00443235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00443235.